| Number of volunteers |
Vaccine 3.75µg HA |
Vaccine 7.5µg HA |
Vaccine 15µg HA |
Placebo |
Total |
| Absolute number |
% |
Absolute number |
% |
Absolute number |
% |
Absolute number |
% |
Absolute number |
% |
| Number of volunteers |
12 |
22.2
(13.2-34.9) |
12 |
22.2
(13.2-34.9) |
12 |
22.2
(13.2-34.9) |
18 |
33.3
(22.2-46.6) |
54 |
100.0
(93.4-100) |
| Number with at least 1 AE |
1 |
8.3
(1.5-35.4) |
3 |
25.0
(8.9-53.2) |
1 |
8.3
(1.5-35.4) |
0 |
0 |
5 |
9.26
(4-19.9) |
| Number with at least one vaccination-related AE |
0 |
0 |
3* |
25.0
(8.9-53.2) |
1** |
8.3
(1.5-35.4) |
0 |
0 |
4 |
7.4
(2.9-17.6) |
| Number with no AE |
11 |
91.6
(64.6-98.5) |
9 |
75.0
(46.8-91.1) |
11 |
91.6
(64.6-98.5) |
18 |
100.0
(82.4-100) |
49 |
90.7
(80.1-96) |
| Number with at least one serious adverse drug reaction |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
*Local reactions of mild intensity occurring within 6 hours of vaccination; **Systemic reactions of moderate intensity occurring within 6 hours of vaccination. |
